• > Synchrotron Light for Drug Discovery
  • NEW CASE STUDY - Titanium Films
  • > Focus on Beamline - I18
  • > The Evolution of VMXi

Synchrotron Services for Industrial Scientists

Welcome to the Industrial Liaison Office. We are here to help you with all aspects of your work with Diamond.
To find out more about how we can help with your project, please select from the following options:


Featured Case Studies

XAS studies of titanium dioxide thin films for memory applications

The Problem profilephoto

Titanium dioxide is one of the most widely used metal oxides and in recent years it has attracted increasing attention in the form of thin films for applications in microelectronics. In particular, it has found potential application in resistive random access memory (RRAM) cells, where the titanium dioxide active layer is sandwiched between two metal electrodes in a metal-insulator-metal (MIM) device architecture. Because of their simple structure, RRAM cells, also known as memristors, can be incorporated into devices with high density that function at low power and high speed. The importance of RRAM devices is due to the fact that they exhibit resistive switching; i.e., they have the ability to toggle their corresponding resistance between high and low resistance states by application of an appropriate voltage. However, this resistive switching mechanism is not currently well understood and is still a matter of debate.


Mechanical Properties of Bacteria

The Problem profilephoto

Antibiotic resistance is an increasingly serious threat to global public health that requires action across all government sectors and society. There are high proportions of antibiotic resistance in bacteria that cause common infections, for example urinary tract infections, and it is patients with these infections caused by drug-resistant bacteria that are generally at increased risk of worse clinical outcomes and death. These patients consume more health-care resources than patients infected with the same bacteria that are drug-resistant. Developing new treatments to tackle this worldwide problem is therefore of paramount importance.


Tackling antibiotic resistance

The Problem profilephoto

Respiratory infections are one of the biggest killers in the western world, and pneumococcal infections can range from mild to potentially deadly. Children and the elderly are most at risk, as well as those with compromised immune systems. There are approximately 90 distinct pneumococcal serotypes and, although not all cause disease, this makes treatment challenging. An effective conjugate vaccine has been available since 2001, however there has been a rise in antibiotic resistance in serotypes not covered by this conjugate vaccine and previously non-infectious serotypes are increasing in virulence. This makes treatment of pneumococcal pneumonia and less severe illnesses such as otitis media more difficult to manage. Therefore finding new approaches to combat pneumococcal disease remains a high priority.


Latest News Subscribe to our newsfeed

  • Feb 1, 2017
    Drug Discovery Using Synchrotron Light

    Drug Discovery Using Synchrotron Light

    Drug Discovery is a lengthy, expensive and complex process. Synchrotron light and advances in techniques, automation, data collection and ...

  • Dec 8, 2016
    Drug discovery goes intracellular

    Drug discovery goes intracellular

    Heptares publish groundbreaking research undertaken at Diamond revealing evidence of a novel binding site on a GPCR CCR9. Read more here....

  • Dec 1, 2016
    Advent Calendar 2016

    Advent Calendar 2016

    Pop in every day to open a new window and find out more about Diamond Light Source and the research that takes place here...

Want to know more?

Please contact us:

Industrial Liaison Office
Tel: +44 (0) 1235 778797
E-mail: industry@diamond.ac.uk

Meet the team...

 Follow us on LinkedIn